Natalie Thomas

Dr. Natalie Thomas

Institute for Social Science Research, Faculty of Humanities and Social Sciences, The University of Queensland, QLD 4072, Australia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in International Journal of Drug Policy
Verified
Journal Article
Closed access
NTNatalie Thomas
Natalie Thomas
KVKatinka van de Ven
Katinka van de Ven
KMKyle J.D. Mulrooney
Kyle J.D. Mulrooney

1 June 2018 in International Journal of Drug Policy
Verified
Journal Article
Closed access
NTNatalie Thomas
Natalie Thomas
MBMelissa Bull
Melissa Bull

10 June 2021 in International Journal of Mental Health and Addiction
Verified
Journal Article
Closed access
PDF file
NTNatalie Thomas
Natalie Thomas
HMHelena Menih
Helena Menih

1 February 2016 in International Journal of Drug Policy
Verified
Journal Article
Closed access
PDF file
NTNatalie Thomas
Natalie Thomas
MBMelissa Bull
Melissa Bull
RDRachel Dioso-Villa
Rachel Dioso-Villa
CSCatrin Smith
Catrin Smith

7 September 2024 in International Journal of Drug Policy
Verified
Journal Article
Open access
JAJane Akhurst
Jane Akhurst
OPOlivia Price
Olivia Price
RSRachel Sutherland
Rachel Sutherland
DGDaisy Gibbs
Daisy Gibbs
PDPaul Dietze
Paul Dietze
APAmy Peacock
Amy Peacock
Examining take-home naloxone (THN) uptake using a 'cascade of care' framework could help identify targets for increasing THN training and carriage among people who may witness or experience opioid overdose. We describe the THN cascade and factors associated with engagement among people who inject drugs. People aged ≥18 years in Australia who inject drugs were interviewed from 2020 to 2022, reporting lifetime THN awareness and acquisition and past-month carriage. We examined factors associated with engagement using multivariable logistic regression. Of 2,149 participants (64 % men, mean age 44.5), 85 % had heard of naloxone, of whom 76 % were aware of THN programs. Of these, 72 % had ever participated in THN training/brief education, 92 % of whom had acquired THN. Of those who had ever acquired THN and reported past-month opioid use, 63 % always/often carried THN when using opioids. Past six-month opioid agonist treatment (OAT) (adjusted odds ratio [AOR] 2.55; 95 %CI 1.91-3.42) and ≥daily injecting (1.32; 1.01-1.73) were associated with awareness. OAT (1.79; 1.38-2.33), past-year opioid overdose (1.68; 1.18-2.42) and older age (1.02; 1.00-1.03) were associated with acquisition. Primarily injecting methamphetamine (versus heroin) in the past month was associated with lower awareness (0.43; 0.31-0.58) and acquisition (0.59; 0.44-0.78). Reporting no accommodation (squatting/sleeping rough) was associated with reduced odds of carriage (0.46; 0.24-0.88). Participants reported high THN awareness and acquisition, with lower carriage. Future efforts should focus on improving THN access and reducing barriers to carriage, particularly for people experiencing homelessness or who primarily inject non-opioids.

1 November 2019 in International Journal of Drug Policy
Verified
Journal Article
Closed access
NTNatalie Thomas
Natalie Thomas
MBMelissa Bull
Melissa Bull
RDRachel Dioso-Villa
Rachel Dioso-Villa
KSKate Smith
Kate Smith